Encontrados 5 documentos, a visualizar página 1 de 1
Association of a genetic variant in the ALOX5AP with higher risk of ischemic st...
Domingues-Montanari, S.; Fernández-Cadenas, I.; Del Rio-Espinola, A.; Corbeto, N.; Krug, T.; Manso, H.; Gouveia, L.; Sobral, J.; Mendioroz, M.Variants in the 5-lipoxygenase-activating protein (ALOX5AP) and phosphodiesterase 4D (PDE4D) genes have first been associated with ischemic stroke (IS) through whole-genome linkage screens. However, association studies obtained conflicting results. We aimed to investigate the contribution of selected single nucleotide polymorphisms (SNPs) in these genes for the first time in a large Iberian population.
Estudios en las Apocynaceae Neotropicales VI: una nueva especie de Prestonia (A...
Morales,J. FranciscoUma nova espécie de Prestonia R. Br., endêmica dos estados do Acre e Amazonas, Brasil, é descrita e ilustrada e se discute as relações com taxas relacionadas.
Reninoma: uma causa rara de hipertensão arterial
Pina, R; Barbosa, B; Morales, J; Correia, J; Teixeira, V; Furtado, AL; Saldanha, MH
Tratamento da disfunção eréctil com autoinjecção intra-cavernosa de substâncias...
Rolo, F; Morales, J; Requixa, A; Mota, A
Early elimination of cyclosporine in kidney transplant recipients receiving sir...
Ruiz, JC; Campistol, JM; Mota, A; Prats, D; Gutiérrez, JA; Castro, A; Morales, JCyclosporine elimination in a regimen including sirolimus has been shown to be a safe and effective approach to improve graft function. Nevertheless, it is still unknown whether the functional benefit of CyA withdrawal coincides with a subsequent reduction in histologic lesions of chronic damage or development of chronic allograft nephropathy. This consideration would forecast a reduction in the rate of long-te...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||